These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 36282174)

  • 21. Construction of a 6-gene prognostic signature to assess prognosis of patients with pancreatic cancer.
    Yang J; Shi W; Zhu S; Yang C
    Medicine (Baltimore); 2020 Sep; 99(37):e22092. PubMed ID: 32925750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated machine learning identifies epithelial cell marker genes for improving outcomes and immunotherapy in prostate cancer.
    Zhu W; Zeng H; Huang J; Wu J; Wang Y; Wang Z; Wang H; Luo Y; Lai W
    J Transl Med; 2023 Nov; 21(1):782. PubMed ID: 37925432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
    Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
    Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
    [No Abstract]   [Full Text] [Related]  

  • 24. An Integrated Machine Learning Framework Identifies Prognostic Gene Pair Biomarkers Associated with Programmed Cell Death Modalities in Clear Cell Renal Cell Carcinoma.
    Chen B; Zhou M; Guo L; Huang H; Sun X; Peng Z; Wu D; Chen W
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):121. PubMed ID: 38538287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A programmed cell death-related model based on machine learning for predicting prognosis and immunotherapy responses in patients with lung adenocarcinoma.
    Zhang Y; Wang Y; Chen J; Xia Y; Huang Y
    Front Immunol; 2023; 14():1183230. PubMed ID: 37671155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic model incorporating immune checkpoint genes to predict the immunotherapy efficacy for lung adenocarcinoma: a cohort study integrating machine learning algorithms.
    Yang XL; Zeng Z; Wang C; Wang GY; Zhang FQ
    Immunol Res; 2024 Aug; 72(4):851-863. PubMed ID: 38755433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An exosome-derived lncRNA signature identified by machine learning associated with prognosis and biomarkers for immunotherapy in ovarian cancer.
    Cui Y; Zhang W; Lu W; Feng Y; Wu X; Zhuo Z; Zhang D; Zhang Y
    Front Immunol; 2024; 15():1228235. PubMed ID: 38404588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated machine learning survival framework develops a prognostic model based on inter-crosstalk definition of mitochondrial function and cell death patterns in a large multicenter cohort for lower-grade glioma.
    Qin H; Abulaiti A; Maimaiti A; Abulaiti Z; Fan G; Aili Y; Ji W; Wang Z; Wang Y
    J Transl Med; 2023 Sep; 21(1):588. PubMed ID: 37660060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-omic profiling reveals potential biomarkers of hepatocellular carcinoma prognosis and therapy response among mitochondria-associated cell death genes in the context of 3P medicine.
    Hu D; Shen X; Gao P; Mao T; Chen Y; Li X; Shen W; Zhuang Y; Ding J
    EPMA J; 2024 Jun; 15(2):321-343. PubMed ID: 38841626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Machine learning framework develops neutrophil extracellular traps model for clinical outcome and immunotherapy response in lung adenocarcinoma.
    Han AX; Long BY; Li CY; Huang DD; Xiong EQ; Li FJ; Wu GL; Liu Q; Yang GB; Hu HY
    Apoptosis; 2024 Aug; 29(7-8):1090-1108. PubMed ID: 38519636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive machine learning-based integration develops a novel prognostic model for glioblastoma.
    Jiang Q; Yang X; Deng T; Yan J; Guo F; Mo L; An S; Huang Q
    Mol Ther Oncol; 2024 Sep; 32(3):200838. PubMed ID: 39072291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma.
    Tang R; Liu X; Liang C; Hua J; Xu J; Wang W; Meng Q; Liu J; Zhang B; Yu X; Shi S
    Front Immunol; 2021; 12():648917. PubMed ID: 33777046
    [No Abstract]   [Full Text] [Related]  

  • 33. A DNA-Methylation-Driven Genes Based Prognostic Signature Reveals Immune Microenvironment in Pancreatic Cancer.
    Xiao M; Liang X; Yan Z; Chen J; Zhu Y; Xie Y; Li Y; Li X; Gao Q; Feng F; Fu G; Gao Y
    Front Immunol; 2022; 13():803962. PubMed ID: 35222383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive machine learning-based preoperative blood features predict the prognosis for ovarian cancer.
    Wu M; Gu S; Yang J; Zhao Y; Sheng J; Cheng S; Xu S; Wu Y; Ma M; Luo X; Zhang H; Wang Y; Zhao A
    BMC Cancer; 2024 Feb; 24(1):267. PubMed ID: 38408960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Machine learning-based integration develops a metabolism-derived consensus model for improving immunotherapy in pancreatic cancer.
    Guo Y; Wang R; Shi J; Yang C; Ma P; Min J; Zhao T; Hua L; Song Y; Li J; Su H
    J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37739440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreatic cancer survival analysis defines a signature that predicts outcome.
    Raman P; Maddipati R; Lim KH; Tozeren A
    PLoS One; 2018; 13(8):e0201751. PubMed ID: 30092011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer.
    Liu Z; Guo C; Dang Q; Wang L; Liu L; Weng S; Xu H; Lu T; Sun Z; Han X
    EBioMedicine; 2022 Jan; 75():103750. PubMed ID: 34922323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Machine learning-based identification of tumor-infiltrating immune cell-associated model with appealing implications in improving prognosis and immunotherapy response in bladder cancer patients.
    Chen H; Yang W; Ji Z
    Front Immunol; 2023; 14():1171420. PubMed ID: 37063886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive analysis of bulk and single-cell transcriptomic data reveals a novel signature associated with endoplasmic reticulum stress, lipid metabolism, and liver metastasis in pancreatic cancer.
    Liu X; Ren B; Fang Y; Ren J; Wang X; Gu M; Zhou F; Xiao R; Luo X; You L; Zhao Y
    J Transl Med; 2024 Apr; 22(1):393. PubMed ID: 38685045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Robust and consistent biomarker candidates identification by a machine learning approach applied to pancreatic ductal adenocarcinoma metastasis.
    Mahawan T; Luckett T; Mielgo Iza A; Pornputtapong N; Caamaño Gutiérrez E
    BMC Med Inform Decis Mak; 2024 Jun; 24(Suppl 4):175. PubMed ID: 38902676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.